Related Experiment Video
Updated: Mar 29, 2026
04:48
Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
7.8K
Colchicine for cardiovascular medicine.
Massimo Imazio1, Fiorenzo Gaita2
1Cardiology Department, Maria Vittoria Hospital & Department of Public Health & Pediatrics, University of Torino, Torino, Italy.
Future Cardiology
|December 4, 2015
Summary
Colchicine, an anti-inflammatory drug, shows promise for preventing cardiovascular events like pericarditis and atrial fibrillation by targeting neutrophil inflammation. Its potential efficacy and safety for these new indications are explored.
Area of Science:
- Cardiovascular Medicine
- Pharmacology
- Inflammation Biology
Background:
- Neutrophils play a key role in inflammatory processes within the cardiovascular system.
- Inflammation contributes to conditions such as pericarditis, atrial fibrillation, and ischemic vascular events.
Purpose of the Study:
- To review the pharmacology of colchicine.
- To explore the potential efficacy and safety of colchicine for emerging cardiovascular indications.
Main Methods:
- Literature review of existing studies on colchicine's pharmacology and cardiovascular applications.
- Analysis of scientific evidence regarding colchicine's anti-inflammatory effects on neutrophils.
Main Results:
- Colchicine exhibits significant anti-inflammatory properties, particularly affecting neutrophil activity.
- Emerging evidence suggests colchicine's potential in managing inflammatory cardiovascular conditions.
Conclusions:
- Colchicine represents a potential therapeutic agent for preventing cardiovascular events driven by inflammation.
- Further research is warranted to establish definitive safety and efficacy profiles for new cardiovascular uses.
Related Concept Videos
01:10Drugs that Destabilize Microtubules
4.3K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.3K
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
4.6K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.6K
01:21Rheumatic Heart Disease III: Medical Management
490
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
490
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.6K
01:17Pericarditis III: Medical Management
511
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
511
01:26Heart Failure Drugs: Inotropic Agents
1.9K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.9K